Antiatherogenic effects of β-adrenergic blocking agents: Theoretical, experimental, and epidemiologic considerations

This publication has 53 references indexed in Scilit:

• Propranolol-induced lipid changes and their prognostic significance after a myocardial infarction: The beta-blocker heart attack trial experience
  The American Journal of Cardiology, 1990
• Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias
  Published by Elsevier ,1990
• Decreased coronary heart disease in hypertensive smokers. Mortality results from the MAPHY study.
  Hypertension, 1989
• Diuretic agents versus beta-blockers. Comparison of effects on mortality, stroke, and coronary events.
  Hypertension, 1989
• Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study
  JAMA, 1988
• Suppression of principal atherosclerotic mechanisms by prostacyclinc and other eicosanoids
  Progress in Lipid Research, 1986
• Medical management of hyperlipidemia and the role of probucol
  The American Journal of Cardiology, 1986
• Unrecognized myocardial infarction and hypertension: The Framingham Study
  American Heart Journal, 1985
• Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbit
  The American Journal of Cardiology, 1984
• ANTI-PLATELET ACTIVITY OF BETA-ADRENERGIC ANTAGONISTS: INHIBITION OF THROMBOXANE SYNTHESIS AND PLATELET AGGREGATION IN PATIENTS RECEIVING LONG-TERM PROPRANOLOL TREATMENT
  The Lancet, 1981